Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer
Clinical trial NCT00912340 · COMPLETED
Trial details
- NCT number
- NCT00912340
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2017-07-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.